Meiju Ji

机构：First Affiliated Hospital of Xi'an Jiaotong University · ORCID：0000-0002-5299-1892

发表论文 147 篇 · 总被引 4584 次 · h-index 39

代表论文

• Disulfiram/copper triggers cGAS-STING innate immunity pathway via ROS-induced DNA damage that potentiates antitumor response to PD-1 checkpoint blockade (2025 · International Journal of Biological Sciences · 被引 18)
• Highly Efficient and Universal Degradation of PD‐L1 via Mitochondrial Oxidative Stress Evoked by Cationic AIE‐Active Photosensitizers for Cancer Immunotherapy (2025 · Advanced Functional Materials · 被引 10)
• Engineering PD-L1 targeted liposomal canagliflozin achieves multimodal synergistic cancer therapy (2024 · Chemical Engineering Journal · 被引 10)
• Targeted degradation of hexokinase 2 by a novel engineered bispecific chimeric liposome-based Nano-PROTACs for enhancing tumor chemotherapy (2025 · Biomaterials · 被引 8)
• Thyrotropin exacerbates insulin resistance by triggering macrophage inflammation in subclinical hypothyroidism (2025 · Experimental & Molecular Medicine · 被引 7)
• High expression of RTEL1 predicates worse progression in gliomas and promotes tumorigenesis through JNK/ELK1 cascade (2024 · BMC Cancer · 被引 7)